CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 98 filers reported holding CULLINAN ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5,075 | +2.3% | 291 | 0.0% | 0.00% | – |
Q1 2024 | $4,959 | +67.3% | 291 | 0.0% | 0.00% | – |
Q4 2023 | $2,965 | +78.9% | 291 | +89.0% | 0.00% | – |
Q2 2023 | $1,657 | -58.1% | 154 | -60.2% | 0.00% | – |
Q1 2023 | $3,959 | -2.5% | 387 | +0.5% | 0.00% | -100.0% |
Q4 2022 | $4,062 | +103.1% | 385 | +116.3% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 178 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 178 | +22.8% | 0.00% | – |
Q1 2022 | $2,000 | – | 145 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 7,648,268 | $98,051,000 | 27.24% |
CHI Advisors LLC | 3,047,609 | $39,070,000 | 14.92% |
Nextech Invest Ltd. | 1,221,145 | $15,655,000 | 5.28% |
BVF INC/IL | 7,509,059 | $96,266,000 | 4.65% |
TANG CAPITAL MANAGEMENT LLC | 609,231 | $7,810,000 | 1.18% |
Boxer Capital, LLC | 1,074,082 | $13,770,000 | 0.87% |
SILVERARC CAPITAL MANAGEMENT, LLC | 213,090 | $2,732,000 | 0.84% |
Atom Investors LP | 96,880 | $1,242,000 | 0.54% |
EcoR1 Capital, LLC | 1,169,889 | $14,998,000 | 0.52% |
Birchview Capital, LP | 45,114 | $578,000 | 0.42% |